Contrast echocardiography in segmental analysis and intraventricular gradient quantification in hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a hereditary disorder characterized by ventricular hypertrophy, diastolic dysfunction and hyperdynamic left ventricular systolic function. This excessive contraction is sometimes associated with significant intraventricular pressure gradients. These gradients are...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista portuguesa de cardiologia 2003-06, Vol.22 (6), p.789-798
Hauptverfasser: Cândido, António, Coucelo, José, Galvão, João, Azevedo, Vanda, Soares, Liselore, Anão, António Oliveira, Bruno, Maria João, Arroja, Isabel, Fernandes, João, Azevedo, José, João, Isabel, Nunes, João Silva, Aleixo, Ana
Format: Artikel
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hypertrophic cardiomyopathy (HCM) is a hereditary disorder characterized by ventricular hypertrophy, diastolic dysfunction and hyperdynamic left ventricular systolic function. This excessive contraction is sometimes associated with significant intraventricular pressure gradients. These gradients are dynamic and therefore vary at different times. Echocardiography can identify and quantify the functional and morphologic changes characteristic of the disease. Ultrasound contrast agents (UCAs) are indicated in patients with poor transthoracic image quality, enabling better visualization of the endocardial border. These agents also strengthen the Doppler signal, which enables better quantification of the transvalvular and intraventricular gradients. In HCM, definition of the endocardial/blood interface and visualization of the myocardial structure, as well as quantification of intraventricular gradients, are fundamental to the study of the pathology. The objective of this study was to evaluate the clinical utility of new UCAs in morphologic study (segmental analysis) and quantification of maximum intraventricular gradients (IVG Max) in HCM, as well as the feasibility and interest of determining mean gradients (IVG Med) in HCM. Thirty-four patients with clinical and echocardiographic diagnosis of HCM were studied. Baseline IVG was considered significant when over 30 mmHg. Left ventricular morphology and IVG quantification were assessed before (study A) and after (study B) UCA injection. Maximum (Max) and mean (Med) values of delta IVG were calculated. Endocardial border definition of ventricular segments was analyzed in studies A and B and the percentage of ventricular segments that were completely visualized throughout the cardiac cycle was established. The mean values of delta IVG Max for studies A and B were 51 +/- 31 mmHg and 61 +/- 32 mmHg, p = NS. The mean values of delta IVG Med were 26 +/- 16 mmHg in study A and 31 +/- 17 mmHg in study B, p = NS. The correlation between delta IVG Max and Med in study A was r2 = 0.74, p < 0.01, while in study B it rose to a value of r2 = 0.82, p < 0.01. Segmental analysis: In all segments studied the visualization percentage was higher after UCA injection, with a statistically significant difference in all lateral and anterior wall segments. HCM is usually evaluated in a non-invasive way by echocardiography. There are no references to systematic use of UCAs in HCM patients. The value of determining the maximum gradient in
ISSN:0870-2551